Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.29%||79.74||0.9%||$563.79m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.06%||126.75||2.0%||$276.96m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.50%||343.30||2.7%||$275.56m|
|VRTX||Vertex Pharmaceuticals Incorporated||0.97%||175.66||1.9%||$265.02m|
|A||Agilent Technologies, Inc.||-0.43%||69.88||1.5%||$176.42m|
|EXAS||Exact Sciences Corporation||0.92%||52.57||25.7%||$143.36m|
|SRPT||Sarepta Therapeutics, Inc.||-0.37%||80.92||16.7%||$123.27m|
|BLUE||Bluebird Bio, Inc.||-6.92%||199.80||15.8%||$122.80m|
|BMRN||BioMarin Pharmaceutical Inc.||0.63%||84.10||4.4%||$104.37m|
Oragenics, Inc. is a biopharmaceutical company. The company is focused on developing novel antibiotics against infectious disease and treatments for oral mucositis. It also develops, markets, and sells proprietary probiotics designed to enhance oral health for humans and pets under Evora and ProBiora brand names. Oragenics was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.